“If the company set a schedule based on any non-
Post# of 148170
(Total Views: 511)
Posted On: 10/19/2020 9:22:59 AM
“If the company set a schedule based on any non-statutory FDA timeline they're fools.”
Very good point here Ohm. There are many opinions on what tomorrow will bring. Some believe the FDA has already seen the data (per Dr. STJ’s comments on October 7) and some believe the DSMC decision came down Thursday and their decision, along with the data, was sent to the FDA for review. The latter is more difficult to comprehend as we know the FDA is not timely in making responses and therefore would make it difficult for CYDY to schedule a CC in anticipation of their response.
Very good point here Ohm. There are many opinions on what tomorrow will bring. Some believe the FDA has already seen the data (per Dr. STJ’s comments on October 7) and some believe the DSMC decision came down Thursday and their decision, along with the data, was sent to the FDA for review. The latter is more difficult to comprehend as we know the FDA is not timely in making responses and therefore would make it difficult for CYDY to schedule a CC in anticipation of their response.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼